As the world enters a phase of the global pandemic marked by an increasing rate of vaccinations, investors are looking for global (particularly, European) healthcare market opportunities. With the emergence of certain...more
9/9/2021
/ Buyers ,
Capital Markets ,
Coronavirus/COVID-19 ,
EBITDA ,
Environmental Social & Governance (ESG) ,
EU ,
Healthcare ,
Investment ,
Investors ,
Market Infrastructure ,
Private Equity ,
Sellers ,
Take-Private Transactions ,
UK
After the COVID-19 slowdown in 2020, the United Kingdom has been one of the most active buyout markets in Europe, with a 60% rise in buyouts in 2021 compared to 2020.
This increase in activity has been driven in part by a...more
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
In a climate where there are so many unknown factors challenging valuation methodologies, we explore a number of mechanisms that European dealmakers may consider during the Coronavirus (COVID-19) pandemic in order to bridge...more
12/4/2020
/ Acquisitions ,
Buyers ,
Coronavirus/COVID-19 ,
Deferred Consideration ,
Earn-Outs ,
EBITDA ,
EU ,
Fairness Standard ,
Fixed Price Contracts ,
Global Dealmaking ,
Indemnity Insurance ,
Mergers ,
Sellers ,
Warranty Insurance
The challenges raised by the Coronavirus (COVID-19) crisis initially led to a dramatic fall in share prices and market uncertainty. Although the capital markets have largely recovered their value since the initial COVID-19...more
In light of the COVID-19 pandemic, the third annual European Healthcare Private Equity Symposium will be conducted as a five-part webinar series, taking place over five weeks in a virtual tour across several European...more
7/6/2020
/ Coronavirus/COVID-19 ,
Health Care Providers ,
Industry Consolidation ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Regulatory Requirements ,
Webinars
In light of the COVID-19 pandemic, the third annual European Healthcare Private Equity Symposium will be conducted as a five-part webinar series, taking place over five weeks in a virtual tour across several European...more
McDermott Will & Emery, in partnership with Alvarez & Marsal is hosting a tailored webinar, discussing the cyber security threats and mitigations facing private equity firms in response to the COVID-19 pandemic.
One of the...more
6/29/2020
/ Coronavirus/COVID-19 ,
Cyber Crimes ,
Cyber Threats ,
Cybersecurity ,
Data Protection ,
Data Security ,
Financial Services Industry ,
Hackers ,
Popular ,
Private Equity ,
Private Equity Firms ,
Ransomware ,
Remote Working ,
Risk Mitigation ,
Webinars
The requirement to stay at home is giving many of us the opportunity to undertake (or no excuse to ignore) the household and DIY tasks at home that have long been at the bottom of the to-do list. Similarly, directors,...more
Few businesses are able to escape the significant disruption caused by the Coronavirus (COVID-19) pandemic and the strict measures imposed by governments to protect their citizens. The pandemic is putting pressure on...more
Following the wider outbreak of the coronavirus (COVID-19) around the world, radical—and sometimes controversial—actions have been and are further expected to be taken by national, federal and local governments and...more
3/16/2020
/ Acquisitions ,
Business Interruption ,
Capital Markets ,
Commercial Insurance Policies ,
Contract Terms ,
Coronavirus/COVID-19 ,
Corporate Financing ,
Corporate Governance ,
Crisis Management ,
Debt Restructuring ,
Emergency Management Plans ,
Employer Responsibilities ,
Health Insurance ,
Healthcare Facilities ,
Life Sciences ,
Mergers ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Regulatory Standards ,
Risk Assessment ,
Risk Mitigation ,
Supply Chain